CardiAMP™ Heart Failure Trial (NCT02438306)

Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy system in Patients with Post Myocardial Infarction Heart Failure.

A clinical trial for patients suffering from heart failure due to a previous heart attack.

PI: Emerson Perin, MD, PhD

SPONSOR: BioCardia, Inc

ACTIVE ENROLLING SIGN UP